Atlas Trials

Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants

Clinical trial NCT05959707 · SUSPENDED

Trial details

NCT number
NCT05959707
Sponsor
HIV Vaccine Trials Network
Status
SUSPENDED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections
Start date
2024-08-14
Primary completion
2025-01-14
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.